Sort by
Neuromodulatory Fragility Is an Upstream Breakpoint for Alzheimer’s Disease Pathogenesis
Alfie Wearn
,Kate M. Onuska
,Taylor W. Schmitz
,Gary R. Turner
,R. Nathan Spreng
Sporadic Alzheimer’s disease (AD) is associated with numerous risk factors, yet its precise cause remains unclear. Here, we describe a novel framework for AD pathogenesis, whereby diverse risk factors converge on neuromodulatory subcortical systems to confer AD risk or resilience. Neuromodulatory projection neurons are uniquely fragile due to their large size, sparse myelination, and high basal metabolic demands. We propose that the increased prevalence of AD in older adult populations likely reflects a universal weakness within these projection systems, which is increasingly exposed as cellular transport and maintenance mechanisms deteriorate with age. The key insight of this ‘neuromodulatory fragility framework’ is that neuromodulatory system dysfunction is sufficient to explain both tau hyperphosphorylation and b-amyloid (Ab) plaque formation, the two pathological hallmarks of AD. We therefore predict that strengthening or preserving the endogenous functions of these systems in midlife represents the most effective strategy for preventing AD.
Sporadic Alzheimer’s disease (AD) is associated with numerous risk factors, yet its precise cause remains unclear. Here, we describe a novel framework for AD pathogenesis, whereby diverse risk factors converge on neuromodulatory subcortical systems to confer AD risk or resilience. Neuromodulatory projection neurons are uniquely fragile due to their large size, sparse myelination, and high basal metabolic demands. We propose that the increased prevalence of AD in older adult populations likely reflects a universal weakness within these projection systems, which is increasingly exposed as cellular transport and maintenance mechanisms deteriorate with age. The key insight of this ‘neuromodulatory fragility framework’ is that neuromodulatory system dysfunction is sufficient to explain both tau hyperphosphorylation and b-amyloid (Ab) plaque formation, the two pathological hallmarks of AD. We therefore predict that strengthening or preserving the endogenous functions of these systems in midlife represents the most effective strategy for preventing AD.
Posted: 05 December 2025
The Impact of Hemichannel-Mediated Neuroinflammation at Early Stages of CNS Ontogeny in the Development of Adult Neuropsychiatric Diseases
Francisco J. Ocaranza
,Juan Carlos Saez
In pathological conditions, elevated activity of connexin and pannexin hemichannels facilitates Adenosine triphosphate (ATP) efflux and Ca2+ influx, activating metabolic pathways of neuroinflammation. While a small insult could result in a protective inflammatory response, more intense and/or prolonged insults induce cell death, causing tissue dysfunction. In the brain, different stressors elevate glucocorticoid (GC) levels that are sensed by mast cells and microglia, and this response persists for a long time, causing continuous inflammasome activation and release of IL-1β and IL-18. These proinflammatory cytokines, together with those released by mast cells, activate astrocytes and oligodendrocytes, which in turn release glutamate and ATP, and altogether reduce neuronal functionality and survival. The extent of neuroinflammation also depends on host features that result in different degrees of alterations during brain ontogeny, consequently changing the brain cytoarchitecture and leading to spectrums of behavioral diseases. Selective hemichannel blockers have been recently discovered and shown to reduce neuroinflammation, as well as neuronal suffering and symptoms linked to adult models of depression and epilepsy. These blockers can serve as tools to dissect the role of neuroinflammation in behavioral diseases. Early treatment during brain ontogeny could reduce detrimental impacts on the brain cytoarchitecture, inducing behavioral alterations elicited in adulthood.
In pathological conditions, elevated activity of connexin and pannexin hemichannels facilitates Adenosine triphosphate (ATP) efflux and Ca2+ influx, activating metabolic pathways of neuroinflammation. While a small insult could result in a protective inflammatory response, more intense and/or prolonged insults induce cell death, causing tissue dysfunction. In the brain, different stressors elevate glucocorticoid (GC) levels that are sensed by mast cells and microglia, and this response persists for a long time, causing continuous inflammasome activation and release of IL-1β and IL-18. These proinflammatory cytokines, together with those released by mast cells, activate astrocytes and oligodendrocytes, which in turn release glutamate and ATP, and altogether reduce neuronal functionality and survival. The extent of neuroinflammation also depends on host features that result in different degrees of alterations during brain ontogeny, consequently changing the brain cytoarchitecture and leading to spectrums of behavioral diseases. Selective hemichannel blockers have been recently discovered and shown to reduce neuroinflammation, as well as neuronal suffering and symptoms linked to adult models of depression and epilepsy. These blockers can serve as tools to dissect the role of neuroinflammation in behavioral diseases. Early treatment during brain ontogeny could reduce detrimental impacts on the brain cytoarchitecture, inducing behavioral alterations elicited in adulthood.
Posted: 04 December 2025
Distinct Role of γ-Synuclein in the Regulation of Motor Performance and Behavioral Responses in Mice
Iuliia S. Sukhanova
,Kirill D. Chaprov
,Olga A. Morozova
,Ruslan K. Ovchinnikov
,Olga A. Kukharskaya
,Valeria N. Zalevskaya
,Nadezhda M. Yusupova
,Anastasia A. Lugovskaya
,Natalia N. Ninkina
,Michail S. Kukharsky
Posted: 04 December 2025
Cell Motility Dynamics in Glaucoma: Mechanisms, Pathogenic Roles, and Therapeutic Targeting
Dario Rusciano
,Caterina Gagliano
,Alessandro Avitabile
,José Fernando Maya-Vetencourt
Cell motility—the dynamic process encompassing migration, adhesion modulation, cytoskeletal remodeling, and extracellular matrix (ECM) interactions—is fundamental to ocular homeostasis. In glaucoma, disrupted motility of trabecular meshwork (TM) and Schlemm’s canal (SC) cells contributes to impaired aqueous humor outflow and elevated intraocular pressure (IOP), while reactive motility of optic nerve head (ONH) glial cells promotes fibrosis and neurodegeneration. Mechanistically, TM/SC motility is regulated by Rho GTPase and ROCK signaling, focal adhesion dynamics, and ECM interactions, while glial cells respond to mechanical stress and cytokines such as TGF-β2. Cytoskeletal alterations, ECM stiffening, and endothelial–mesenchymal transition (EndMT) contribute to glaucomatous damage by reducing normal cell motility and tissue remodeling capacity. Aberrant motility at the ONH, including heterogeneous astrocytic reactivity, leads to lamina cribrosa remodeling and retinal ganglion cell degeneration. Therapeutically, ROCK inhibitors improve TM/SC motility and outflow, suppress EndMT, and may confer neuroprotection. Stem cell–based strategies and modulation of TGF-β2 or mechanotransduction pathways represent emerging approaches to restore physiological motility and regenerative potential. Despite promising advances, challenges remain in ensuring targeted, durable, and safe modulation of cellular dynamics. Understanding and therapeutically harnessing cell motility offers a unifying framework to address both pressure-dependent and neurodegenerative mechanisms in glaucoma.
Cell motility—the dynamic process encompassing migration, adhesion modulation, cytoskeletal remodeling, and extracellular matrix (ECM) interactions—is fundamental to ocular homeostasis. In glaucoma, disrupted motility of trabecular meshwork (TM) and Schlemm’s canal (SC) cells contributes to impaired aqueous humor outflow and elevated intraocular pressure (IOP), while reactive motility of optic nerve head (ONH) glial cells promotes fibrosis and neurodegeneration. Mechanistically, TM/SC motility is regulated by Rho GTPase and ROCK signaling, focal adhesion dynamics, and ECM interactions, while glial cells respond to mechanical stress and cytokines such as TGF-β2. Cytoskeletal alterations, ECM stiffening, and endothelial–mesenchymal transition (EndMT) contribute to glaucomatous damage by reducing normal cell motility and tissue remodeling capacity. Aberrant motility at the ONH, including heterogeneous astrocytic reactivity, leads to lamina cribrosa remodeling and retinal ganglion cell degeneration. Therapeutically, ROCK inhibitors improve TM/SC motility and outflow, suppress EndMT, and may confer neuroprotection. Stem cell–based strategies and modulation of TGF-β2 or mechanotransduction pathways represent emerging approaches to restore physiological motility and regenerative potential. Despite promising advances, challenges remain in ensuring targeted, durable, and safe modulation of cellular dynamics. Understanding and therapeutically harnessing cell motility offers a unifying framework to address both pressure-dependent and neurodegenerative mechanisms in glaucoma.
Posted: 03 December 2025
From Stress to Substance Use Disorders: The Expanding Role of Microglia-Astrocytes Cross-Talk in Neuroimmune and Glutamate Alterations in the Nucleus Accumbens
Liliana Marina Cancela
,Bethania Mongi-Bragato
,María Paula Avalos
,Flavia Andrea Bollati
Posted: 03 December 2025
Pandemic Babies: Developmental Outcomes in Preschool-Aged Children Born During the COVID-19 Era
Sally Sade
,Claudia L. R. Gonzalez
,Robbin L. Gibb
Posted: 02 December 2025
Modulation of Behavioral, Biochemical, Immunomodulatory, and Transcriptional Profiles by the Strain Limosilactobacillus fermentum U-21 in Combined Model of Parkinson’s Disease in Rats Wistar
Diana A. Reznikova
,Olga B. Bekker
,Alla V. Stavrovskaya
,Dmitry N. Voronkov
,Andrei A. Gerasimov
,Anastasiia K. Pavlova
,Ivan A. Potapov
,Mikhail V. Ivanov
,Veronika S. Letvinova
,Maya V. Odorskaya
+4 authors
Posted: 02 December 2025
Roles of Extracellular Regulated Kinase 1/2 (ERK 1/2), Including form Activated by BDNF/TrkB, and Their Contribution in Neurodegenerative Diseases
Tadahiro Numakawa
,Ryutaro Kajihara
Posted: 02 December 2025
Beta Oscillations as a Mechanistic Target for Predictive Processing Deficits in Psychosis
Hsi (Tiana) Wei
,Lindsey Power
,Krishna D. Singh
,Lena Palaniyappan
Background: Predictive processing abnormalities offer a unifying account of perceptual and expressive disturbances in psychosis, yet classical predictive coding frameworks remain difficult to translate due to limited neurophysiological grounding. Emerging evidence positions beta-band oscillations and their transient burst dynamics as a biologically plausible mechanism for implementing top-down predictions that stabilize internal models. Study Design: This narrative review synthesizes evidence from electrophysiology, laminar physiology, computational modelling, language research, and clinical neuroimaging to evaluate beta oscillations as a mechanistic target for predictive processing deficits in psychosis. We integrate data from modified predictive routing frameworks and dendritic computation models to clarify how beta rhythms prepare cortical pathways for predicted inputs. Study Results: Across sensory, motor, cognitive, and language domains, schizophrenia features impaired generation, timing, and contextual deployment of beta activity. These include attenuated post-movement beta rebound, reduced or mistimed beta bursts during working memory and inhibition, abnormal beta-gamma interactions during perception, and weakened beta-mediated contextual guidance during language comprehension. Laminar and computational findings indicate that beta bursts arise from the integration of apical (contextual) and basal (sensory) dendritic inputs in layer 5 pyramidal neurons, providing a mechanistic substrate for top-down predictions. Beta disruptions, therefore, offer a parsimonious account of disorganization, psychomotor slowing, and failures of contextual maintenance. Early neuromodulation, pharmacologic, and neurofeedback studies suggest that beta dynamics are modifiable. Conclusions: Beta oscillations provide a tractable and mechanistically grounded target for predictive processing deficits in psychosis. Standardizing burst metrics and developing individualized, closed-loop approaches will be critical for advancing beta-based interventions.
Background: Predictive processing abnormalities offer a unifying account of perceptual and expressive disturbances in psychosis, yet classical predictive coding frameworks remain difficult to translate due to limited neurophysiological grounding. Emerging evidence positions beta-band oscillations and their transient burst dynamics as a biologically plausible mechanism for implementing top-down predictions that stabilize internal models. Study Design: This narrative review synthesizes evidence from electrophysiology, laminar physiology, computational modelling, language research, and clinical neuroimaging to evaluate beta oscillations as a mechanistic target for predictive processing deficits in psychosis. We integrate data from modified predictive routing frameworks and dendritic computation models to clarify how beta rhythms prepare cortical pathways for predicted inputs. Study Results: Across sensory, motor, cognitive, and language domains, schizophrenia features impaired generation, timing, and contextual deployment of beta activity. These include attenuated post-movement beta rebound, reduced or mistimed beta bursts during working memory and inhibition, abnormal beta-gamma interactions during perception, and weakened beta-mediated contextual guidance during language comprehension. Laminar and computational findings indicate that beta bursts arise from the integration of apical (contextual) and basal (sensory) dendritic inputs in layer 5 pyramidal neurons, providing a mechanistic substrate for top-down predictions. Beta disruptions, therefore, offer a parsimonious account of disorganization, psychomotor slowing, and failures of contextual maintenance. Early neuromodulation, pharmacologic, and neurofeedback studies suggest that beta dynamics are modifiable. Conclusions: Beta oscillations provide a tractable and mechanistically grounded target for predictive processing deficits in psychosis. Standardizing burst metrics and developing individualized, closed-loop approaches will be critical for advancing beta-based interventions.
Posted: 01 December 2025
Mental Imagery in Fencing: Improving Point Control and Lunge Distance Through Visualization
Troy Song
,Adam Liu
,Kun Liu
Posted: 28 November 2025
Frequency-Dependent Synaptic Plasticity and Homeostatic Regulation under Rhythmic Modulation of In Vitro Hippocampal Networks
Shutong Sun
,Longhui Jiang
,Yaoyao Liu
,Li Shang
,Chengji Lu
,Shangchen Li
,Kui Zhang
,Mixia Wang
,Xinxia Cai
,Jinping Luo
Posted: 26 November 2025
CRISPR-Enabled Functional Genomics in hPSC-Derived Neural Models for Autism Spectrum Disorder
S.T. Gopukumar
,Madhumita Saha
,Tanveen Kaur Soni
,Samer Shamshad
,Sunil Tadakod
,Alok Sharma
,Uddalak Das
Autism Spectrum Disorder (ASD) is a genetically heterogeneous neurodevelopmental condition driven by rare de novo variants, copy number variations, and polygenic risk. SFARI-curated genes show high mutational constraint and enriched expression in cortical neurons and glia. This review highlights recent advances in CRISPR-based functional genomics using human pluripotent stem cells and induced pluripotent stem cells differentiated into neural progenitors, excitatory and inhibitory neurons, astrocytes, microglia, and brain organoids. CRISPR modalities including knockouts, CRISPRi and CRISPRa, base and prime editing, and Cas13 enable pooled and arrayed screens with high coverage at low multiplicity of infection. Integration of multimodal readouts such as Perturb-seq, single-cell and spatial transcriptomics, proximity labeling proteomics, and functional assays including microelectrode arrays and calcium imaging provides system-level insights into ASD gene function. Computational frameworks like MIMOSCA and SCEPTRE facilitate network reconstruction and pseudo-time inference. Case studies reveal Wnt and BAF complex dysregulation, microglial pruning deficits, and non-cell autonomous effects. Translational approaches target haplo-insufficient genes such as CHD8 and SCN2A using AAV or antisense oligonucleotides supported by isogenic iPSC models. Remaining challenges include model immaturity and scalability, while future directions focus on spatial perturb-omics, AI-driven causal inference, and standardized biobanks for precision ASD therapeutics.
Autism Spectrum Disorder (ASD) is a genetically heterogeneous neurodevelopmental condition driven by rare de novo variants, copy number variations, and polygenic risk. SFARI-curated genes show high mutational constraint and enriched expression in cortical neurons and glia. This review highlights recent advances in CRISPR-based functional genomics using human pluripotent stem cells and induced pluripotent stem cells differentiated into neural progenitors, excitatory and inhibitory neurons, astrocytes, microglia, and brain organoids. CRISPR modalities including knockouts, CRISPRi and CRISPRa, base and prime editing, and Cas13 enable pooled and arrayed screens with high coverage at low multiplicity of infection. Integration of multimodal readouts such as Perturb-seq, single-cell and spatial transcriptomics, proximity labeling proteomics, and functional assays including microelectrode arrays and calcium imaging provides system-level insights into ASD gene function. Computational frameworks like MIMOSCA and SCEPTRE facilitate network reconstruction and pseudo-time inference. Case studies reveal Wnt and BAF complex dysregulation, microglial pruning deficits, and non-cell autonomous effects. Translational approaches target haplo-insufficient genes such as CHD8 and SCN2A using AAV or antisense oligonucleotides supported by isogenic iPSC models. Remaining challenges include model immaturity and scalability, while future directions focus on spatial perturb-omics, AI-driven causal inference, and standardized biobanks for precision ASD therapeutics.
Posted: 26 November 2025
Cortical Neuroplasticity and fNIRS Seed Based Connectivity in Adolescent HIV: A Pilot Randomised Clinical Trial
Sizwe Zondo
,Duane Booysen
Posted: 26 November 2025
Epigenetic Dysregulation in Rett Syndrome: Multisystem Pathophysiology, MECP2 Isoform-Specific Mechanisms, and Targeted Therapeutic Strategies
S.T. Gopukumar
,Madhumita Saha
,Sahil Bhardwaj
,Tanveen Kaur Soni
,Samer Shamshad
,Uddalak Das
Posted: 26 November 2025
Chronic Multi-Electrode Spinal Cord Electrical Stimulation and Electromyography Platform in Non-Human Primates
Alena Militskova
,Vyacheslav Andrianov
,Artur Biktimirov
,Evgeny Gulaev
,Tatiana Alfimova
,Matvey Shkap
,Larisa Burachek
,Roman Panfilov
,Dmitry V. Bulgin
,Sergey Zhirnov
+3 authors
Posted: 25 November 2025
Toward an Integrative Model of Flashbacks — The Hippocampal Drive for Coherence
Mario J. Passaro
Posted: 25 November 2025
Obesity and Insulin Resistance Alter Neural Processing of Unpleasant, but Not Pleasant, Visual Stimuli in Young Adults
Brittany A. Larsen
,Brandon S. Klinedinst
,Tovah Wolf
,Kelsey E. McLimans
,Qian Wang
,Parvin Mohammadiarvejeh
,Mohammad Fili
,Azizi Seixas
,Auriel A. Willette
Posted: 24 November 2025
The Impact of a Rosemary Containing Drink on Cognition and Mood: The Role of Eye Blink Dynamics
Leigh Martin Riby
,Dimana Kardzhieva
,Sam Fenwick
,Sofia Fowler
,Mark Moss
Posted: 20 November 2025
Do Humans (and Animals) Think in Poetic Language?
Arturo Tozzi
Posted: 18 November 2025
The Traditional Autonomic Narrative Misleads Yet Persists — A Critical Review and Proposed Alternative to Replace It
David Adelson
Posted: 17 November 2025
of 44